These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33111489)

  • 1. Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts.
    Espejo-Mojica AJ; Rodríguez-López A; Li R; Zheng W; Alméciga-Díaz CJ; Dulcey-Sepúlveda C; Combariza G; Barrera LA
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):885-895. PubMed ID: 33111489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
    Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
    Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
    Tsuji D
    Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma G
    Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
    Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
    Weil D; Van Cong N; Rebourcet R; Frézal J
    Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
    Beutler E; Kuhl W; Comings D
    Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
    Kitakaze K; Tasaki C; Tajima Y; Hirokawa T; Tsuji D; Sakuraba H; Itoh K
    Biochem Biophys Rep; 2016 Sep; 7():157-163. PubMed ID: 28955902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase Vector.
    Osmon KJ; Thompson P; Woodley E; Karumuthil-Melethil S; Heindel C; Keimel JG; Kaemmerer WF; Gray SJ; Walia JS
    Curr Gene Ther; 2022; 22(3):262-276. PubMed ID: 34530708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.
    Ou L; Przybilla MJ; Tăbăran AF; Overn P; O'Sullivan MG; Jiang X; Sidhu R; Kell PJ; Ory DS; Whitley CB
    Gene Ther; 2020 May; 27(5):226-236. PubMed ID: 31896760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosphingolipid degradation and animal models of GM2-gangliosidoses.
    Kolter T; Sandhoff K
    J Inherit Metab Dis; 1998 Aug; 21(5):548-63. PubMed ID: 9728335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation.
    Castejón-Vega B; Rubio A; Pérez-Pulido AJ; Quiles JL; Lane JD; Fernández-Domínguez B; Cachón-González MB; Martín-Ruiz C; Sanz A; Cox TM; Alcocer-Gómez E; Cordero MD
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.
    Tsuji D; Akeboshi H; Matsuoka K; Yasuoka H; Miyasaki E; Kasahara Y; Kawashima I; Chiba Y; Jigami Y; Taki T; Sakuraba H; Itoh K
    Ann Neurol; 2011 Apr; 69(4):691-701. PubMed ID: 21520232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
    Matsuoka K; Tamura T; Tsuji D; Dohzono Y; Kitakaze K; Ohno K; Saito S; Sakuraba H; Itoh K
    Mol Ther; 2011 Jun; 19(6):1017-24. PubMed ID: 21487393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
    Utsumi K; Tsuji A; Kase R; Tanaka A; Tanaka T; Uyama E; Ozawa T; Sakuraba H; Komaba Y; Kawabe M; Iino Y; Katayama Y
    Acta Neurol Scand; 2002 Jun; 105(6):427-30. PubMed ID: 12027830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and Therapies for GM2 Gangliosidosis.
    Cachon-Gonzalez MB; Zaccariotto E; Cox TM
    Curr Gene Ther; 2018; 18(2):68-89. PubMed ID: 29618308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
    Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
    Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.